{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:21:46Z","timestamp":1783441306475,"version":"3.54.6"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.phrs.2023.106956","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T23:13:54Z","timestamp":1697498034000},"page":"106956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Sex-oriented perspectives in immunopharmacology"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-4876","authenticated-orcid":false,"given":"Andrea","family":"Cignarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Vegeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bolego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Trabace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ortona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2023.106956_bib1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2217\/imt-2018-0002","article-title":"An overview of cancer immunotherapeutic strategies","volume":"10","author":"Wahid","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.phrs.2023.106956_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of IBD: targets, mechanisms and related therapies","volume":"71-72","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.phrs.2023.106956_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and Anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations","volume":"8","author":"Seidel","year":"2018","journal-title":"Front Oncol."},{"key":"10.1016\/j.phrs.2023.106956_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2023.106956_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","article-title":"CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy","volume":"41","author":"Pan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.phrs.2023.106956_bib6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3390\/ijms19030768","article-title":"Structural biology of the TNF\u03b1 antagonists used in the treatment of rheumatoid arthritis","volume":"19","author":"Lim","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106956_bib7","doi-asserted-by":"crossref","first-page":"2185035","DOI":"10.1080\/19490976.2023.2185035","article-title":"The role of the sex hormone-gut microbiome axis in tumor immunotherapy","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2023.106956_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/159150","article-title":"Sex hormones and immune dimorphism","volume":"2014","author":"Bhatia","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.phrs.2023.106956_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-8993(02)03475-3","article-title":"Age and gender effects on microglia and astrocyte numbers in brains of mice","volume":"956","author":"Mouton","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.phrs.2023.106956_bib11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1471-4159.2011.07630.x","article-title":"Sex differences in microglial colonization of the developing rat brain","volume":"120","author":"Schwarz","year":"2012","journal-title":"J. Neurochem"},{"key":"10.1016\/j.phrs.2023.106956_bib12","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.3390\/ijms20153809","article-title":"Early sex differences in the immune-inflammatory responses to neonatal ischemic stroke","volume":"20","author":"Villapol","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106956_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.resmic.2019.03.003","article-title":"Serum level of sex steroid hormone is associated with diversity and profiles of human gut microbiome","volume":"170","author":"Shin","year":"2019","journal-title":"Res Microbiol"},{"key":"10.1016\/j.phrs.2023.106956_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2019.07.025","article-title":"Metabolic functions of gut microbes associate with efficacy of tumor necrosis factor antagonists in patients with inflammatory bowel diseases","volume":"157","author":"Aden","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2023.106956_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106870","article-title":"MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis","volume":"194","author":"Datta","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2023.106956_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.trsl.2021.01.009","article-title":"Influence of immunomodulatory drugs on the gut microbiota","volume":"233","author":"Cohen","year":"2021","journal-title":"Transl. Res"},{"key":"10.1016\/j.phrs.2023.106956_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.phrs.2023.106956_bib18","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3390\/cancers12102983","article-title":"The confounders of cancer immunotherapy: roles of lifestyle, metabolic disorders and sociological factors","volume":"12","author":"Deshpande","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phrs.2023.106956_bib19","first-page":"158","article-title":"Gender-related differences in lifestyle may affect health status","volume":"52","author":"Var\u00ec","year":"2016","journal-title":"Ann. Ist. Super. Sanita"},{"key":"10.1016\/j.phrs.2023.106956_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib21","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.phrs.2023.106956_bib22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/art.41587","article-title":"Expert perspective: immune checkpoint inhibitors and rheumatologic complications","volume":"73","author":"Cappelli","year":"2021","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccell.2022.06.005","article-title":"Sex and cancer immunotherapy: current understanding and challenges","volume":"40","author":"Pala","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2023.106956_bib24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1470-2045(18)30261-4","article-title":"Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis","volume":"19","author":"Conforti","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2023.106956_bib25","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/1078-0432.CCR-21-0136","article-title":"Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion","volume":"27","author":"Conforti","year":"2021","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.phrs.2023.106956_bib26","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2023.106956_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11096-022-01395-7","article-title":"Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system","volume":"44","author":"Chen","year":"2022","journal-title":"Int J. Clin. Pharm."},{"key":"10.1016\/j.phrs.2023.106956_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","article-title":"Sex-specific cardiovascular risks of cancer and its therapies","volume":"130","author":"Wilcox","year":"2022","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2023.106956_bib29","first-page":"96","article-title":"Biologic therapies and autoimmune phenomena","volume":"32","author":"Drosos","year":"2021","journal-title":"Mediterr. J. Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1741-7015-11-88","article-title":"Biologic therapy for autoimmune diseases: an update","volume":"11","author":"Rosman","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.phrs.2023.106956_bib31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/bcp.13185","article-title":"First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis","volume":"83","author":"Glatt","year":"2017","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.phrs.2023.106956_bib32","first-page":"CD011535","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"7","author":"Sbidian","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2023.106956_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/jpm12030499","article-title":"Focus on sex and gender: what we need to know in the management of rheumatoid arthritis","volume":"12","author":"Maranini","year":"2022","journal-title":"J. Pers. Med"},{"key":"10.1016\/j.phrs.2023.106956_bib34","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/ard.2009.119933","volume":"69","author":"Emery","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib35","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2023.106956_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3899\/jrheum.110610","article-title":"British Society for Rheumatology Biologics Register. Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology Biologics Register","volume":"39","author":"Soliman","year":"2012","journal-title":"J. Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.2010.137703","article-title":"IMAGE Investigators. Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial","volume":"70","author":"Tak","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib38","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2023.106956_bib39","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/rheumatology\/keu176","article-title":"Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry","volume":"53","author":"Couderc","year":"2014","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.phrs.2023.106956_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13293-020-00301-y","article-title":"The impact of sex and gender on immunotherapy outcomes","volume":"11","author":"Klein","year":"2020","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.phrs.2023.106956_bib41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbrc.2013.10.042","article-title":"Gender difference in tumor necrosis factor-\u03b1 production in human neutrophils stimulated by lipopolysaccharide and interferon-\u03b3","volume":"441","author":"Aomatsu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2023.106956_bib42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00024382-200116050-00003","article-title":"Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model","volume":"16","author":"Asai","year":"2001","journal-title":"Shock"},{"key":"10.1016\/j.phrs.2023.106956_bib43","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T","article-title":"Sexual dimorphism in innate immunity","volume":"46","author":"Moxley","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2023.106956_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","article-title":"Gender differences in axial spondyloarthritis: women are not so lucky","volume":"20","author":"Rusman","year":"2018","journal-title":"Curr. Rheuma Rep."},{"key":"10.1016\/j.phrs.2023.106956_bib45","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/jcm10071441","article-title":"Sex-related differences in drugs with anti-inflammatory properties","volume":"10","author":"Farkouh","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.phrs.2023.106956_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1196\/annals.1351.037","article-title":"Anti-TNF and sex hormones","volume":"1069","author":"Cutolo","year":"2006","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.phrs.2023.106956_bib47","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/ard.2006.066761","article-title":"Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial","volume":"66","author":"Burmester","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-4632.2011.04871.x","article-title":"TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists","volume":"50","author":"Williams","year":"2011","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.phrs.2023.106956_bib49","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.3748\/wjg.v18.i47.6967","article-title":"Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease","volume":"18","author":"Zelinkova","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2023.106956_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2036.2003.01411.x","article-title":"Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model","volume":"17","author":"Crandall","year":"2003","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.phrs.2023.106956_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gut.2008.163642","article-title":"Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study","volume":"58","author":"Fidder","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2023.106956_bib52","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2023.106956_bib53","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/acr.21762","article-title":"Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients","volume":"64","author":"Jawaheer","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"Suppl 3","key":"10.1016\/j.phrs.2023.106956_bib54","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.phrs.2023.106956_bib55","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3899\/jrheum.110548","article-title":"Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis \u2014 results from the DANBIO Registry","volume":"39","author":"Jawaheer","year":"2012","journal-title":"J. Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/ard.2006.056937","article-title":"Sex: a major predictor of remission in early rheumatoid arthritis?","volume":"66","author":"Forslind","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib57","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","article-title":"Predictors of response to anti-TNF-\u03b1 therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"45","author":"Hyrich","year":"2006","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.phrs.2023.106956_bib58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/rheumatology\/ker250","article-title":"Early Rheumatoid Arthritis Study (ERAS). Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDs","volume":"51","author":"Jayakumar","year":"2012","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.phrs.2023.106956_bib59","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/03009742.2019.1602670","article-title":"Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population","volume":"48","author":"Hambardzumyan","year":"2019","journal-title":"Scand. J. Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib60","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00296-014-2999-x","article-title":"Biologic therapy response and drug survival for females compared to males with rheumatoid arthritis: a cohort study","volume":"34","author":"Lee","year":"2014","journal-title":"Rheuma Int"},{"key":"10.1016\/j.phrs.2023.106956_bib61","first-page":"523","article-title":"Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases","volume":"55","author":"Souto","year":"2016","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.phrs.2023.106956_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/369202","article-title":"How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis","volume":"2013","author":"Chou","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2040622317743486","article-title":"New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice","volume":"9","author":"Dubash","year":"2018","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib64","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1023\/A:1018895500721","article-title":"Quantitative PCR analysis of TNF-\u03b1 and IL-1\u03b2 mRNA levels in pediatric IBD mucosal biopsies","volume":"42","author":"Dionne","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2023.106956_bib65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ibd.20759","article-title":"Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid na\u00efve ulcerative colitis during active and quiescent disease","volume":"15","author":"Matsuda","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/325129","article-title":"Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease","volume":"2014","author":"\u015alebioda","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.phrs.2023.106956_bib67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrrheum.2017.187","article-title":"Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment","volume":"13","author":"Kalden","year":"2017","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib68","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/ijms18091973","article-title":"Can we predict the efficacy of anti-TNF-\u03b1 agents?","volume":"18","author":"Lopetuso","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2023.106956_bib69","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/1756-185X.13271","article-title":"Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice","volume":"21","author":"Rusman","year":"2018","journal-title":"Int J. Rheum. Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib70","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/j.gastro.2018.06.043","article-title":"Sex-based differences in incidence of inflammatory bowel diseases \u2013 pooled analysis of population-based studies from Western countries","volume":"155","author":"Shah","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2023.106956_bib71","first-page":"1609","article-title":"Group for the Study of Inflammatory Bowel Diseases from Madrid. Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response","volume":"55","author":"Gonzalez-Lama","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.phrs.2023.106956_bib72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1157\/13125587","article-title":"Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response","volume":"31","author":"Gonz\u00e1lez-Lama","year":"2008","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2023.106956_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fphar.2019.00047","article-title":"Sex differences in response to TNF-inhibiting drugs in patients with spondyloarthropathies or inflammatory bowel diseases","volume":"10","author":"Lagan\u00e0","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2023.106956_bib74","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/MIB.0000000000001072","article-title":"Treatment persistence for infliximab versus adalimumab in Crohn\u2019s disease: a 14-year single-center experience","volume":"23","author":"Olivera","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102648","article-title":"Tackling the autoimmune side in spondyloarthritis: a systematic review","volume":"19","author":"Chimenti","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2023.106956_bib76","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001681","article-title":"Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients","volume":"7","author":"Chimenti","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.phrs.2023.106956_bib77","doi-asserted-by":"crossref","first-page":"961","DOI":"10.55563\/clinexprheumatol\/dz0xrd","article-title":"Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study","volume":"39","author":"D'Angelo","year":"2021","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3899\/jrheum.17666","article-title":"The sex influence on response to tumor necrosis factor-\u03b1 inhibitors and remission in axial spondyloarthritis","volume":"45","author":"Lubrano","year":"2018","journal-title":"J. Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/art.39464","article-title":"Sexual dimorphism in the Th17 signature of ankylosing spondylitis","volume":"68","author":"Gracey","year":"2016","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib80","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.12688\/f1000research.9592.1","article-title":"Recent advances in understanding and managing psoriatic arthritis","volume":"5","author":"Gladman","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.phrs.2023.106956_bib81","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2023.106956_bib82","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2012-201357","article-title":"Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis","volume":"72","author":"Eder","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib83","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/acr.24090","article-title":"Determinants of patient-reported psoriatic arthritis impact of disease: an analysis of the association with sex in 458 patients from fourteen countries","volume":"72","author":"Orbai","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.phrs.2023.106956_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/482691","article-title":"Clinical differences between men and women with psoriatic arthritis: relevance of the analysis of genes and polymorphisms in the major histocompatibility complex region and of the age at onset of psoriasis","volume":"2013","author":"Queiro","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib85","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s10067-017-3769-4","article-title":"A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors","volume":"36","author":"Chimenti","year":"2017","journal-title":"Clin. Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib86","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/key140","article-title":"Gender differences in biologic treatment outcomes \u2013 a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers","volume":"57","author":"H\u00f8jgaard","year":"2018","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.phrs.2023.106956_bib87","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3899\/jrheum.181272","article-title":"Real-world longterm effectiveness of tumor necrosis factor inhibitors in psoriatic arthritis patients from the Rheumatic Diseases Portuguese Register","volume":"47","author":"Vieira-Sousa","year":"2020","journal-title":"J. Rheuma"},{"key":"10.1016\/j.phrs.2023.106956_bib88","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/ar2670","article-title":"British Society for Rheumatology Biologics Register. Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register","volume":"11","author":"Saad","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.phrs.2023.106956_bib89","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ard.2009.111856","article-title":"Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions","volume":"69","author":"Van den Bosch","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2023.106956_bib90","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fncel.2013.00065","article-title":"Functional diversity of microglia - how heterogeneous are they to begin with?","volume":"7","author":"Hanisch","year":"2013","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.phrs.2023.106956_bib92","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","article-title":"Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution","volume":"566","author":"Masuda","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2023.106956_bib93","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41582-021-00463-2","article-title":"Multifaceted microglia - key players in primary brain tumour heterogeneity","volume":"17","author":"Keane","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2023.106956_bib94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1126\/science.aau9100","article-title":"Targeting microglia in brain disorders","volume":"365","author":"Priller","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.phrs.2023.106956_bib95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2023.106956_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639613","article-title":"Single-cell transcriptomics and in situ morphological analyses reveal microglia heterogeneity across the nigrostriatal pathway","volume":"12","author":"Uriarte Huarte","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib97","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41593-022-01095-5","article-title":"Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling","volume":"25","author":"Kumar","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2023.106956_bib98","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.23962","article-title":"A loss of mature microglial markers without immune activation in schizophrenia","volume":"69","author":"Snijders","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2023.106956_bib99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbi.2017.03.010","article-title":"Sex differences in microglial phagocytosis in the neonatal hippocampus","volume":"64","author":"Nelson","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2023.106956_bib100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/glia.23263","article-title":"Sex differences in the phagocytic and migratory activity of microglia and their impairment by palmitic acid","volume":"66","author":"Yanguas-Cas\u00e1s","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2023.106956_bib101","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbi.2018.07.023","article-title":"Depletion of embryonic microglia using the CSF1R inhibitor PLX5622 has adverse sex-specific effects on mice, including accelerated weight gain, hyperactivity and anxiolytic-like behaviour","volume":"73","author":"Rosin","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2023.106956_bib102","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.celrep.2018.08.001","article-title":"Transcriptional and translational differences of microglia from male and female brains","volume":"24","author":"Guneykaya","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2023.106956_bib103","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.celrep.2018.05.048","article-title":"Sex-specific features of microglia from adult mice","volume":"23","author":"Villa","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2023.106956_bib104","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nn1254","article-title":"Induction of PGE2 by estradiol mediates developmental masculinization of sex behavior.","volume":"7","author":"Amateau","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2023.106956_bib105","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1523\/JNEUROSCI.1268-12.2013","article-title":"Microglia are essential to masculinization of brain and behavior","volume":"33","author":"Lenz","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2023.106956_bib106","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yfrne.2018.11.003","article-title":"Sexual differentiation of microglia","volume":"52","author":"Villa","year":"2019","journal-title":"Front Neuroendocr."},{"key":"10.1016\/j.phrs.2023.106956_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2019.100787","article-title":"Molecular mechanisms and cellular events involved in the neuroprotective actions of estradiol \u2013 analysis of sex differences","volume":"55","author":"Azcoitia","year":"2019","journal-title":"Front Neuroendocr."},{"key":"10.1016\/j.phrs.2023.106956_bib108","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.yfrne.2008.04.001","article-title":"Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases","volume":"29","author":"Vegeto","year":"2008","journal-title":"Front Neuroendocr."},{"key":"10.1016\/j.phrs.2023.106956_bib109","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/er.2016-1007","article-title":"Estrogens, neuroinflammation, and neurodegeneration","volume":"37","author":"Villa","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phrs.2023.106956_bib110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001967","article-title":"Sex disparities in stroke: women have more severe strokes but better survival than men","volume":"4","author":"Dehlendorff","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2023.106956_bib111","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/endrev\/bnz005","article-title":"The role of sex and sex hormones in neurodegenerative diseases","volume":"41","author":"Vegeto","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phrs.2023.106956_bib112","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13311-016-0483-x","article-title":"Inflammation and stroke: an overview","volume":"13","author":"Anrather","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2023.106956_bib113","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1177\/0271678X17694185","article-title":"Depletion of microglia exacerbates postischemic inflammation and brain injury","volume":"37","author":"Jin","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.phrs.2023.106956_bib114","doi-asserted-by":"crossref","first-page":"11499","DOI":"10.1038\/ncomms11499","article-title":"Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke","volume":"7","author":"Szalay","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2023.106956_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104349","article-title":"Inflammation within the neurovascular unit \u2013 focus on microglia for stroke injury and recovery","volume":"147","author":"Eldahshan","year":"2019","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2023.106956_bib116","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00401-004-0918-z","article-title":"Human cerebral infarct: a proposed histopathologic classification based on 137 cases","volume":"108","author":"Mena","year":"2004","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2023.106956_bib117","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-018-1246-x","article-title":"The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation","volume":"15","author":"Zhang","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2023.106956_bib118","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/jcbfm.2014.186","article-title":"Sex differences in ischemic stroke sensitivity are influenced by gonadal hormones, not by sex chromosome complement","volume":"35","author":"Manwani","year":"2015","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.phrs.2023.106956_bib119","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/STROKEAHA.122.039138","article-title":"Sex differences in poststroke inflammation: a focus on microglia across the lifespan","volume":"53","author":"Ugidos","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2023.106956_bib120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jneuroim.2014.11.020","article-title":"Splenectomy reduces infarct volume and neuroinflammation in male but not female mice in experimental stroke","volume":"278","author":"Dotson","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phrs.2023.106956_bib121","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cellimm.2017.06.003","article-title":"Sex differences in regulatory cells in experimental stroke","volume":"318","author":"Seifert","year":"2017","journal-title":"Cell Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib122","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/STROKEAHA.115.008897","article-title":"IL-4 Is required for sex differences in vulnerability to focal ischemia in mice","volume":"46","author":"Xiong","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2023.106956_bib123","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12272-022-01406-1","article-title":"Advanced therapeutic strategies targeting microglia: beyond neuroinflammation","volume":"45","author":"Kwon","year":"2022","journal-title":"Arch. Pharm. Res"},{"key":"10.1016\/j.phrs.2023.106956_bib124","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/ane.12296","article-title":"An open-label evaluator-blinded clinical study of minocycline neuroprotection in ischemic stroke: gender-dependent effect","volume":"131","author":"Amiri-Nikpour","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.phrs.2023.106956_bib125","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.jcbfm.9600059","article-title":"Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection","volume":"25","author":"McCullough","year":"2005","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.phrs.2023.106956_bib126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41586-019-1088-4","article-title":"CD22 blockade restores homeostatic microglial phagocytosis in ageing brains","volume":"568","author":"Pluvinage","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2023.106956_bib127","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303760120","article-title":"CARD9 attenuates A\u03b2 pathology and modifies microglial responses in an Alzheimer's disease mouse model","volume":"120","author":"Ennerfelt","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2023.106956_bib128","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1523\/JNEUROSCI.2427-21.2022","article-title":"Microglial mTOR activation upregulates Trem2 and enhances \u03b2-amyloid plaque clearance in the 5XFAD Alzheimer's disease model","volume":"42","author":"Shi","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2023.106956_bib129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fimmu.2017.00066","article-title":"Tumor-associated lymphatic vessels upregulate PDL1 to inhibit T-cell activation","volume":"8","author":"Dieterich","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib130","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.169.7.3581","article-title":"B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis","volume":"169","author":"Mazanet","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2023.106956_bib132","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41556-020-0562-4","article-title":"Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy","volume":"22","author":"Gao","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2023.106956_bib133","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fimmu.2019.00086","article-title":"Elevated soluble PD-L1 in pregnant women's serum suppresses the immune reaction","volume":"10","author":"Okuyama","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2023.106956_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114670","article-title":"Sex-dependent PD-L1\/sPD-L1 trafficking in human endothelial cells in response to inflammatory cytokines and VEGF","volume":"162","author":"Baggio","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2023.106956_bib135","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/cvr\/cvab096","article-title":"Clinical efficacy and safety of angiogenesis inhibitors: sex differences and current challenges","volume":"118","author":"Cignarella","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2023.106956_bib136","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bph.14524","article-title":"Histamine pharmacology: from Sir Henry Dale to the 21st century","volume":"177","author":"Tiligada","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2023.106956_bib137","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/bph.12801","article-title":"Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants","volume":"172","author":"Wifling","year":"2015","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2023.106956_bib138","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.pbb.2004.09.014","article-title":"Sex differences in mouse behavior following pyrilamine treatment: role of histamine 1 receptors in arousal","volume":"79","author":"Easton","year":"2004","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.phrs.2023.106956_bib139","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuroscience.2015.06.049","article-title":"Sex- and afferent-specific differences in histamine receptor expression in vagal afferents of rats: a potential mechanism for sexual dimorphism in prevalence and severity of asthma","volume":"303","author":"Li","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2023.106956_bib140","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7150\/ijbs.7595","article-title":"Gender differences in histamine-induced depolarization and inward currents in vagal ganglion neurons in rats","volume":"9","author":"Li","year":"2013","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.phrs.2023.106956_bib141","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/jcem-52-5-924","article-title":"The effect of histamine and H1 and H2 receptors on prolactin and luteinizing hormone release in humans: sex differences and the role of stress","volume":"52","author":"Pontiroli","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.106956_bib142","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1042\/CS20171505","article-title":"Defining the role of glucocorticoids in inflammation","volume":"132","author":"Ronchetti","year":"2018","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.phrs.2023.106956_bib143","doi-asserted-by":"crossref","first-page":"ra74","DOI":"10.1126\/scisignal.2001077","article-title":"Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence","volume":"3","author":"Duma","year":"2010","journal-title":"Sci. Signal"},{"key":"10.1016\/j.phrs.2023.106956_bib144","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1096\/fj.15-278309","article-title":"Endogenous hepatic glucocorticoid receptor signaling coordinates sex-biased inflammatory gene expression","volume":"30","author":"Quinn","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2023.106956_bib145","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s13311-017-0557-4","article-title":"Ocrelizumab and other CD20(+) B-cell-depleting therapies in multiple sclerosis","volume":"14","author":"Gelfand","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2023.106956_bib146","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1056\/NEJMct071462","article-title":"Natalizumab for multiple sclerosis","volume":"356","author":"Ransohoff","year":"2007","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2023.106956_bib147","first-page":"495","article-title":"The influence of interferon \u03b2-1b on gut microbiota composition in patients with multiple sclerosis","volume":"36","author":"Castillo-Alvarez","year":"2021","journal-title":"Neurologia"},{"key":"10.1016\/j.phrs.2023.106956_bib148","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1172\/JCI8970","article-title":"Glatiramer acetate (Copaxone\u00ae) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis","volume":"105","author":"Duda","year":"2000","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2023.106956_bib149","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fneur.2018.00005","article-title":"Emerging understanding of the mechanism of action for dimethyl fumarate in the treatment of multiple sclerosis","volume":"9","author":"Mills","year":"2018","journal-title":"Front Neurol."},{"key":"10.1016\/j.phrs.2023.106956_bib150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.imbio.2014.12.008","article-title":"Phenotypic activation and pharmacological outcomes of spontaneously differentiated human monocyte-derived macrophages","volume":"220","author":"Tedesco","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.phrs.2023.106956_bib151","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.yfrne.2018.07.001","article-title":"A case for gender-based approach to multiple sclerosis therapeutics","volume":"50","author":"Houtchens","year":"2018","journal-title":"Front Neuroendocr."},{"key":"10.1016\/j.phrs.2023.106956_bib152","doi-asserted-by":"crossref","unstructured":"Herold K.C., Gitelman S.E., Ehlers M.R., Gottlieb P.A., Greenbaum C.J., Hagopian W., Boyle K.D., Keyes-Elstein L., Aggarwal S., Phippard D., Sayre P.H., McNamara J., Bluestone J.A.; AbATE Study Team. Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders. Diabetes, 62, 2013: 3766\u20133774. doi: 10.2337\/db13\u20130345.","DOI":"10.2337\/db13-0345"},{"key":"10.1016\/j.phrs.2023.106956_bib153","doi-asserted-by":"crossref","unstructured":"Herold K.C., Bundy B.N., Long S.A., Bluestone J.A., DiMeglio L.A., Dufort M.J., Gitelman S.E., Gottlieb P.A., Krischer J.P., Linsley P.S., Marks J.B., Moore W., Moran A., Rodriguez H., Russell W.E., Schatz D., Skyler J.S., Tsalikian E., Wherrett D.K., Ziegler A.G., Greenbaum C.J.; Type 1 Diabetes TrialNet Study Group. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med., 381, 2019: 603\u2013613. doi: 10.1056\/NEJMoa1902226.","DOI":"10.1056\/NEJMoa1902226"},{"key":"10.1016\/j.phrs.2023.106956_bib154","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2023.106956_bib155","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1172\/JCI14257","article-title":"Autoimmune type 1 diabetes: resolved and unresolved issues","volume":"108","author":"Notkins","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2023.106956_bib156","doi-asserted-by":"crossref","unstructured":"Braffett B.H., Bebu I., El Ghormli L., Cowie C.C., Sivitz W.I., Pop-Busui R., Larkin M.E., Gubitosi-Klug R.A., Nathan D.M., Lachin J.M., Dagogo-Jack S.; DCCT\/EDIC Research Group. Cardiometabolic risk factors and incident cardiovascular disease events in women vs men with type 1 diabetes. JAMA Netw Open, 5, 2022: e2230710. doi: 10.1001\/jamanetworkopen.2022.30710.","DOI":"10.1001\/jamanetworkopen.2022.30710"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:48:16Z","timestamp":1760914096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823003122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":156,"alternative-id":["S1043661823003122"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106956","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-oriented perspectives in immunopharmacology","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106956"}}